-
Accelerate early drug development with our Synthesis-to-Clinic service
-
Quotient Bioresearch presents comprehensive drug development capabilities via new company website
2 February 2010 -
11th Annual Phase I Clinical Trials/5th Annual Bioanalysis in Clinical Research, 23-25 February, London UK
Welcome
Quotient is a leading provider of early stage and specialist drug development services to pharmaceutical, biotechnology and medical device clients worldwide.
Underpinned by a unique combination of medical and scientific capabilities, we continually strive to deliver the highest quality of service to our clients - in support of your endeavours to develop new and pioneering medicines and products. Our innovative range of services are provided on a standalone basis, or integrated, to deliver your bespoke development programmes.
From small molecules through to biopharmaceuticals and biomarkers, we are ready to answer your question.
